Shopping Cart
- Remove All
- Your shopping cart is currently empty
Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $619 | In Stock | |
10 mg | $877 | In Stock | |
25 mg | $1,280 | In Stock | |
50 mg | $1,750 | In Stock | |
100 mg | $2,360 | In Stock |
Description | Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers. |
Alias | JNJ-61610588 |
Molecular Weight | 144.52 kDa |
Cas No. | 1969313-51-6 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.